Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

P-3074 effectively blocks scalp DHT better than oral finasteride.

The document's conclusion cannot be provided because the content is not available.

Post-finasteride syndrome causes various symptoms in men using finasteride, with no known cure.

BSSP may help skin tumors grow and could be a marker or target for skin cancer treatment.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

A new mutation in the FLCN gene linked to Birt-Hogg-Dube syndrome was found, suggesting people with certain lung collapse should be tested for this mutation and screened for kidney and colon cancer.

A girl with a rare skin condition improved after one month of treatment with acitretin.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Impaired LEF1 activation speeds up skin cell development in Hutchinson-Gilford Progeria Syndrome.

SP1 promotes and KROX20 inhibits hair cell growth by affecting the CUX1 gene.

Accurate diagnosis of EFFC is crucial for effective counseling and cosmetic care.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

The woman has a rare, harmless skin condition specific to pregnancy that causes itchy bumps and will go away after she gives birth.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

Faulty LEF1 activation causes faster skin cell differentiation in premature aging syndrome.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

SMAs improve patient satisfaction and may be cost-effective for female hair loss.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Early diagnosis and quick treatment improve life quality for FFA patients.

Using finasteride with TIP extends time off period for prostate cancer patients.

Tph cells are linked to the severity of systemic lupus erythematosus.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

A woman developed folliculitis after taking acitretin for psoriasis, which was treated with skin dressing and antibiotics.

Substance P may contribute to hair loss by increasing oxidative stress and mitochondrial activity in hair follicles.